4D Molecular Therapeutics shares fall 5.19% premarket despite upcoming investor conferences in September.

martes, 26 de agosto de 2025, 4:24 am ET1 min de lectura
FDMT--
4D Molecular Therapeutics, Inc. fell 5.19% in premarket trading. The company announced that its management will participate in upcoming investor conferences in September, including the Cantor Global Healthcare Conference, H.C. Wainwright 27th Annual Global Investment Conference, and Morgan Stanley Annual Global Healthcare Conference.

4D Molecular Therapeutics shares fall 5.19% premarket despite upcoming investor conferences in September.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios